Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 96 Rectal Neoplasms 45 Colorectal Neoplasms 45 Carcinoma, Non-Small-Cell Lung 31 Esophageal Neoplasms 28 Esophageal Squamous Cell Carcinoma 24 Stomach Neoplasms 22 Lung Neoplasms 20 Pancreatic Neoplasms 19 Squamous Cell Carcinoma of Head and Neck 18 Colonic Neoplasms 18 Sarcoma 16 Neoplasms 16 Adenocarcinoma Of Esophagus 15 Ovarian Neoplasms 14 Neoplasm Metastasis 14 Head and Neck Neoplasms 14 Carcinoma, Hepatocellular 14 Prostatic Neoplasms 13 Urinary Bladder Neoplasms 12 Uterine Cervical Neoplasms 10 Inflammatory Breast Neoplasms 9 Fallopian Tube Neoplasms 9 Osteosarcoma 8 Central Nervous System Neoplasms 8 Carcinoma, Intraductal, Noninfiltrating 8 Kidney Neoplasms 7 Carcinoma, Ovarian Epithelial 7 Recurrence 6 Multiple Myeloma 6

Interventions

Dexamethasone 111 Cyclophosphamide 99 Melphalan 91 Bortezomib 69 Peripheral Blood Stem Cell Transplantation 64 Lenalidomide 58 fludarabine phosphate 56 Busulfan 54 Filgrastim 50 Tacrolimus 38 Antilymphocyte Serum 38 Thalidomide 36 Radiotherapy 36 Mycophenolic Acid 33 fludarabine 28 Cyclosporine 26 Methotrexate 25 Etoposide 22 Calcium Dobesilate 22 Whole-Body Irradiation 21 Prednisone 21 Methylprednisolone 20 sargramostim 19 pomalidomide 19 Granulocyte Colony-Stimulating Factor 18 carfilzomib 16 daratumumab 15 Cord Blood Stem Cell Transplantation 15 Carmustine 14 Rituximab 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Neoadjuvant Therapy × Clear all

NCT01554852 2018-06-11

Myeloma XI

University of Leeds

Phase 3 Unknown

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡